Bárbara Peters, PhD, Clinical Innovation Lead, IFF Health Sciences, will present how probiotics can contribute to maintaining a balanced vaginal microbiota and supporting women’s intimate health.
The presentation will review recent studies on the efficacy of different probiotic strains, their clinical applications, and the potential of probiotics as an innovative approach to gynecological care. Attendees will gain a clear and up-to-date overview of the latest scientific advances in this field.
September 12, 10:35 am
Women’s health is a dynamic and evolving landscape, with specific needs at each stage of life. And it’s an area that IFF Health Sciences has been exploring for more than two decades.
The global women’s health market is expected to reach a staggering $60 billion by 2030¹, reflecting a growing recognition of the importance of addressing these unique requirements. With this growth, purchases of women’s health products continue to increase across a range of care areas.
We’d love to talk to you about how our microbiome and bioscience expertise can help you develop, manufacture and deliver solutions that enable people at all life stages to live healthier and happier lives.